2nd Quarter - Report

GOVERNMENT COUNSEL, LLC for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General issues relating to PBM point of sale rebates, spread pricing and price transparency.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

RIN 0936-AA08: Fraud and Abuse; Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees; S.476-The Creating Transparency to Have Drug Rebates Unlocked Act; S. 1895-Lower Health Care Costs ActSection relating to Section 306; H.R. 2113-Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act of 2019; H.R. 2376- & S. 1227-The Prescription Pricing for the People Act; H.R.- 2115, the Public Disclosures of Drug Discounts Act.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2113 (116th), H.R. 2376 (116th), S. 1227 (116th), S. 476 (116th), S. 1895 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.